Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
<p>Abstract</p> <p>Background</p> <p>c-Met is a receptor tyrosine kinase (RTK) that is over-expressed in a variety of cancers and involved in cell growth, invasion, metastasis and angiogenesis. In this study, we investigated the role of c-Met in rhabdomyosarcoma (RMS) u...
Main Authors: | Li Yan, Zheng Jialin, Wang Jing, Geng Liying, Sun Lijun, Dong Jixin, Hou Jinxuan, Bridge Julia, Hinrichs Steven H, Ding Shi-Jian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/9/1/64 |
Similar Items
-
Activation of ERK–p53 and ERK-Mediated Phosphorylation of Bcl-2 Are Involved in Autophagic Cell Death Induced by the c-Met Inhibitor SU11274 in Human Lung Cancer A549 Cells
by: Ying Liu, et al.
Published: (2012-01-01) -
Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib.
by: Gang Chen, et al.
Published: (2013-01-01) -
Law 11.274/2006 and its implications in the everyday practice of reading and writing classes
by: Leonete Luzia Schmidt, et al.
Published: (2016-06-01) -
Activated O2•− and H2O2 Mediated Cell Survival in SU11274-Treated Non-Small-Cell Lung Cancer A549 Cells via c-Met–PI3K–Akt and c-Met–Grb2/SOS–Ras–p38 Pathways
by: Ying Liu, et al.
Published: (2012-01-01) -
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression
by: Clara Perrone, et al.
Published: (2022-04-01)